The asthma control rate achieved by budesonide/formoterol in clinical practice in China
Study identifier:NIS-RCN-SYM-2012/1
ClinicalTrials.gov identifier:NCT01785901
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
The asthma control rate achieved by budesonide/formoterol in clinical practice in China
Medical condition
asthma
Phase
-
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
1502
Study type
Observational
Age
18 Years +
Date
Study Start Date: 01 May 2013
Primary Completion Date: 01 Oct 2014
Study Completion Date: 01 Oct 2014
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Aug 2016 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| Target subject population 1500 Asthma patients who have already received the treatment of budesonide/formoterol by physicians’ determination and whose medications are aligned with the package insert of budesonide/formoterol approved in China | Other: without interventions without interventions Other Name: without interventions |
